A new trading day began on Tuesday, with Dyne Therapeutics Inc (NASDAQ: DYN) stock price down -1.54% from the previous day of trading, before settling in for the closing price of $13.67. DYN’s price has ranged from $13.40 to $47.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 12.26%. With a float of $77.75 million, this company’s outstanding shares have now reached $101.75 million.
The extent of productivity of a business whose workforce counts for 141 workers is very important to gauge. In terms of profitability, gross margin is 64.28%, operating margin of -8301.64%, and the pretax margin is -7774.92%.
Dyne Therapeutics Inc (DYN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Dyne Therapeutics Inc is 23.60%, while institutional ownership is 86.77%. The most recent insider transaction that took place on Dec 11 ’24, was worth 65,632. In this transaction Chief Scientific Officer of this company sold 2,334 shares at a rate of $28.12, taking the stock ownership to the 201,685 shares. Before that another transaction happened on Dec 11 ’24, when Company’s SVP, Head of Finance & Admin. sold 1,455 for $28.12, making the entire transaction worth $40,915. This insider now owns 127,078 shares in total.
Dyne Therapeutics Inc (DYN) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 12.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.02% during the next five years compared to -106.26% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Here are Dyne Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 17.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.56, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -3.76 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
The latest stats from [Dyne Therapeutics Inc, DYN] show that its last 5-days average volume of 4.68 million was superior to 3.18 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 10.26%. Additionally, its Average True Range was 1.36.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 0.94%, which indicates a significant decrease from 1.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 148.11% in the past 14 days, which was higher than the 82.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.11, while its 200-day Moving Average is $31.74. Now, the first resistance to watch is $13.86. This is followed by the second major resistance level at $14.26. The third major resistance level sits at $14.58. If the price goes on to break the first support level at $13.15, it is likely to go to the next support level at $12.83. The third support level lies at $12.43 if the price breaches the second support level.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
With a market capitalization of 1.37 billion, the company has a total of 101,766K Shares Outstanding. Currently, annual sales are 0 K while annual income is -235,940 K. The company’s previous quarter sales were 0 K while its latest quarter income was -97,130 K.
